Expression profile of matrix metalloproteinase-2 and -9 and their endogenous tissue inhibitors in osteonecrotic femoral heads

International Journal of Molecular Medicine

Volumn 26, Issue 1, 2010, Pages 127-133

  Grässel, Susanne ^a,b   Beckmann, Johannes ^a   Rath, Björn ^a   Vogel, Mandy ^a,b   Grifka, Joachim ^a   Tingart, Markus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Centre for Medical Biotechnology   (Germany)

Author keywords

Collagen; Matrix metalloproteinase; Osteoarthritis; Osteonecrosis; Tissue inhibitor matrix metalloprotease

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE BIOPSY; BONE MATRIX; BONE REMODELING; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMUR HEAD NECROSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MACROMOLECULE; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOARTHRITIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77954743146     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000444     Document Type: Article

References (39)

1. Calder JD, Pearse MF and Revell PA: The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br 83: 419-422, 2001.
2. Mont MA and Hungerford DS: Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77: 459-474, 1995.
3. Tingart M, Bathis H, Perlick L, Lerch K, Luring C and Grifka J: [Therapy of femoral head osteonecrosis: results of a national survey]. Z Orthop Ihre Grenzgeb 142: 553-558, 2004.
4. Kim YH and Kim JS: Histologic analysis of acetabular and proximal femoral bone in patients with osteonecrosis of the femoral head. J Bone Joint Surg Am 86-A: 2471-2474, 2004.
5. Laroche M, Costa L, Bernard J, et al: Dual-energy X-ray absorptiometry in osteonecrosis of the femoral head. Rev Rhum Engl Ed 65: 393-396, 1998. (Pubitemid 28328950)
6. Radke S, Battmann A, Jatzke S, Eulert J, Jakob F and Schutze N: Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 24: 945-952, 2006.
7. Jingushi S, Lohmander LS, Shinmei M, et al: Markers of joint tissue turnover in joint fluids from hips with osteonecrosis of the femoral head. J Orthop Res 18: 728-733, 2000.
8. Karsenty G: How many factors are required to remodel bone? Nat Med 6: 970-971, 2000.
9. Murphy G, Knauper V, Atkinson S, et al: Matrix metalloproteinases in arthritic disease. Arthritis Res 4 (suppl 3): 39-49, 2002.
10. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001. (Pubitemid 33096184)
11. Kusano K, Miyaura C, Inada M, et al: Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139: 1338-1345, 1998.
12. Lorenzo JA, Pilbeam CC, Kalinowski JF and Hibbs MS: Production of both 92- and 72-kDa gelatinases by bone cells. Matrix 12: 282-290, 1992.
13. Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D and Redini F: Regulation of osteoclast protease expression by RANKL. Biochem Biophys Res Commun 310: 774-778, 2003.
14. Duerr S, Stremme S, Soeder S, Bau B and Aigner T: MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin Exp Rheumatol 22: 603-608, 2004. (Pubitemid 39310477)
15. Vu TH, Shipley JM, Bergers G, et al: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422, 1998.
16. Panagakos FS and Kumar S: Differentiation of human osteoblastic cells in culture: modulation of proteases by extracellular matrix and tumor necrosis factor-alpha. Inflammation 19: 423-443, 1995.
17. De Bart AC, Quax PH, Lowik CW and Verheijen JH: Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. J Bone Miner Res 10: 1374-1384, 1995.
18. Cook TF, Burke JS, Bergman KD, Quinn CO, Jeffrey JJ and Partridge NC: Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells. Arch Biochem Biophys 311: 313-320, 1994.
19. Bord S, Horner A, Beeton CA, Hembry RM and Compston JE: Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone 24: 229-235, 1999.
20. Butler GS, Butler MJ, Atkinson SJ, et al: The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871-880, 1998.
21. Goldring MB: The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 40: 1-11, 1999. (Pubitemid 29139343)
22. De Ceuninck F, Dassencourt L and Anract P: The inflammatory side of human chondrocytes unveiled by antibody microarrays. Biochem Biophys Res Commun 323: 960-969, 2004.
23. Stashenko P, Dewhirst FE, Peros WJ, Kent RL and Ago JM: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138: 1464-1468, 1987.
24. Bertolini DR, Nedwin GE, Bringman TS, Smith DD and Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516-518, 1986.
25. Ficat RP: Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br 67: 3-9, 1985.
26. Tingart M, Beckmann J, Opolka A, et al: Influence of factors regulating bone formation and remodeling on bone quality in osteonecrosis of the femoral head. Calcif Tissue Int 82: 300-308, 2008.
27. Wong ML and Medrano JF: Real-time PCR for mRNA quantitation. Biotechniques 39: 75-85, 2005.
28. Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193, 2000.
29. Dreier R, Wallace S, Fuchs S, Bruckner P and Grassel S: Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9). J Cell Sci 114: 3813-3822, 2001.
30. Xue M, March L, Sambrook PN and Jackson CJ: Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. Arthritis Rheum 56: 2864-2874, 2007.
31. Galligan L, Livingstone W, Volkov Y, et al: Characterization of protein C receptor expression in monocytes. Br J Haematol 115: 408-414, 2001.
32. Fahling M, Steege A, Perlewitz A, et al: Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochim Biophys Acta 1731: 32-40, 2005.
33. Limaye AM, Desai KV, Chavalmane AK and Kondaiah P: Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate. Mol Cell Endocrinol 294: 10-18, 2008.
34. Xu M, Scott JE, Liu KZ, et al: The influence of nicotine on granulocytic differentiation - inhibition of the oxidative burst and bacterial killing and increased matrix metalloproteinase-9 release. BMC Cell Biol 9: 19-25, 2008.
35. Pruijt JF, Fibbe WE, Laterveer L. et al: Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci USA 96: 10863-10868, 1999.
36. Baker AH, Edwards DR and Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115: 3719-3727, 2002.
37. Sobue T, Hakeda Y, Kobayashi Y, et al: Tissue inhibitor of metalloproteinases 1 and 2 directly stimulate the bone-resorbing activity of isolated mature osteoclasts. J Bone Miner Res 16: 2205-2214, 2001. (Pubitemid 33104710)
38. Kivirikko KI: Collagen biosynthesis: a mini-review cluster. Matrix Biol 16: 355-356, 1998.
39. Beckmann J, Matsuura M, Grassel S, Kock F, Grifka J and Tingart M: A muCT analysis of the femoral bone stock in osteonecrosis of the femoral head compared to osteoarthrosis. Arch Orthop Trauma Surg 129: 501-505, 2009.